Comment from American College of Cardiology

Summary: The American College of Cardiology supports the FTC's policy statement against the suppression of accuracy in AI systems, particularly regarding deceptive marketing of AI-enabled health wearables. They recommend that the FTC clarify how "accuracy" is evaluated in clinical contexts, ensure that safety-related performance balancing is not misconstrued as deception, and clarify that clinicians are not obligated to monitor every alert from patient-owned devices.